HALOZYME THERAPEUTICS INC (HALO) Stock Analyst Earnings Estimates
NASDAQ:HALO - Nasdaq - US40637H1095 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 660.1M 48.91% | 829.253M 25.63% | 1.015B 22.44% | 1.212B 19.37% | 1.492B 23.10% | 1.686B 13.00% | 1.862B 10.44% | 1.723B -7.47% | 1.603B -6.96% | 1.485B -7.36% | 1.268B -14.61% | |
| EBITDA YoY % growth | 339M 21.55% | 424.93M 25.35% | 632.787M 48.92% | 789.58M 24.78% | 1.06B 34.25% | 1.106B 4.34% | 1.218B 10.13% | 1.14B -6.40% | 1.046B -8.25% | N/A | N/A | |
| EBIT YoY % growth | 289.4M 4.89% | 340.074M 17.51% | 551.475M 62.16% | 694.03M 25.85% | 922.51M 32.92% | 1.072B 16.20% | 1.315B 22.67% | 1.075B -18.25% | 1.001B -6.88% | 846.6M -15.42% | 603.84M -28.67% | |
| Operating Margin | 43.84% | 41.01% | 54.32% | 57.26% | 61.83% | 63.58% | 70.62% | 62.39% | 62.45% | 57.01% | 47.62% | |
| EPS YoY % growth | 2.22 15.62% | 2.78 25.23% | 4.23 52.16% | 5.00 18.18% | 6.60 31.98% | 8.06 22.20% | 9.21 14.21% | 8.72 -5.25% | 8.30 -4.91% | 7.00 -15.59% | 5.75 -17.84% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.94 19.21% | 1.18 29.65% | 1.40 10.43% | 1.55 23.32% | 1.37 45.85% | 1.53 29.97% | 1.70 21.45% | 1.84 18.60% |
| Revenue Q2Q % growth | 233.88M 19.40% | 285.98M 23.61% | 338.62M 16.73% | 359.81M 20.74% | 321.69M 37.54% | 361.91M 26.55% | 401.73M 18.64% | 424.52M 17.98% |
| EBITDA Q2Q % growth | 133.3M 15.16% | 170.97M 8.37% | 219.95M -1.85% | 245.89M -4.25% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 121.21M 26.87% | 162.99M 39.03% | 204.25M 25.16% | 219.21M 24.91% | 197.9M 63.27% | 224.52M 37.75% | 254.07M 24.39% | 268.27M 22.38% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.26 53.66% | 1.18 | 0.08 | 6.64% |
| Q3 2024 Q2Q % growth | 1.27 69.33% | 1.00 | 0.27 | 26.79% |
| Q2 2024 Q2Q % growth | 0.91 22.97% | 0.77 | 0.14 | 17.68% |
| Q1 2024 Q2Q % growth | 0.79 68.09% | 0.71 | 0.08 | 11.44% |
| Q4 2023 Q2Q % growth | 0.82 70.83% | 0.84 | -0.02 | -2.55% |
| Q3 2023 Q2Q % growth | 0.75 1.35% | 0.72 | 0.03 | 3.96% |
| Q2 2023 Q2Q % growth | 0.74 39.62% | 0.64 | 0.10 | 15.31% |
| Q1 2023 Q2Q % growth | 0.47 | 0.49 | -0.02 | -3.40% |
| Q4 2022 Q2Q % growth | 0.48 14.29% | 0.48 | 0.00 | 1.02% |
| Q3 2022 Q2Q % growth | 0.74 45.10% | 0.52 | 0.22 | 41.37% |
| Q2 2022 Q2Q % growth | 0.53 -14.52% | 0.51 | 0.02 | 3.58% |
| Q1 2022 Q2Q % growth | 0.47 27.03% | 0.50 | -0.03 | -5.96% |
| Q4 2021 Q2Q % growth | 0.42 -16.00% | 0.41 | 0.01 | 1.36% |
| Q3 2021 Q2Q % growth | 0.51 104.00% | 0.43 | 0.08 | 18.20% |
| Q2 2021 Q2Q % growth | 0.62 226.32% | 0.42 | 0.20 | 47.85% |
| Q1 2021 Q2Q % growth | 0.37 1,025.00% | 0.32 | 0.05 | 14.15% |
| Q4 2020 Q2Q % growth | 0.50 308.33% | 0.54 | -0.04 | -8.15% |
| Q3 2020 Q2Q % growth | 0.25 247.06% | 0.20 | 0.05 | 25.88% |
| Q2 2020 Q2Q % growth | 0.19 290.00% | 0.25 | -0.06 | -24.33% |
| Q1 2020 Q2Q % growth | -0.04 -500.00% | -0.02 | -0.02 | -89.17% |
| Q4 2019 Q2Q % growth | -0.24 | -0.16 | -0.08 | -52.89% |
| Q3 2019 Q2Q % growth | -0.17 | -0.12 | -0.05 | -37.17% |
| Q2 2019 Q2Q % growth | -0.10 | -0.14 | 0.04 | 30.57% |
| Q1 2019 Q2Q % growth | 0.01 | 0.01 | 0.00 | -29.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 298.008M 29.55% | 294.01M | 3.998M | 1.36% |
| Q3 2024 Q2Q % growth | 290.084M 34.28% | 256.08M | 34.004M | 13.28% |
| Q2 2024 Q2Q % growth | 231.353M 4.67% | 209.04M | 22.313M | 10.67% |
| Q1 2024 Q2Q % growth | 195.879M 20.81% | 203.77M | -7.891M | -3.87% |
| Q4 2023 Q2Q % growth | 230.039M 26.74% | 235.76M | -5.721M | -2.43% |
| Q3 2023 Q2Q % growth | 216.033M 3.37% | 220.43M | -4.397M | -1.99% |
| Q2 2023 Q2Q % growth | 221.038M 45.04% | 203.95M | 17.088M | 8.38% |
| Q1 2023 Q2Q % growth | 162.143M 38.23% | 179.02M | -16.877M | -9.43% |
| Q4 2022 Q2Q % growth | 181.5M 77.94% | 195.9M | -14.4M | -7.35% |
| Q3 2022 Q2Q % growth | 209M 80.48% | 194.93M | 14.07M | 7.22% |
| Q2 2022 Q2Q % growth | 152.4M 11.65% | 141.56M | 10.84M | 7.66% |
| Q1 2022 Q2Q % growth | 117.3M 31.80% | 130.82M | -13.52M | -10.33% |
| Q4 2021 Q2Q % growth | 102M -16.19% | 102.33M | -330K | -0.32% |
| Q3 2021 Q2Q % growth | 115.8M 77.34% | 107.74M | 8.06M | 7.48% |
| Q2 2021 Q2Q % growth | 136.5M 147.28% | 106.13M | 30.37M | 28.62% |
| Q1 2021 Q2Q % growth | 89M 250.39% | 86.576M | 2.424M | 2.80% |
| Q4 2020 Q2Q % growth | 121.7M 126.63% | 122.57M | -870K | -0.71% |
| Q3 2020 Q2Q % growth | 65.3M 41.34% | 62.12M | 3.18M | 5.12% |
| Q2 2020 Q2Q % growth | 55.2M 41.18% | 68.01M | -12.81M | -18.84% |
| Q1 2020 Q2Q % growth | 25.4M -55.36% | 43.821M | -18.421M | -42.04% |
| Q4 2019 Q2Q % growth | 53.7M | 58.067M | -4.367M | -7.52% |
| Q3 2019 Q2Q % growth | 46.2M | 56.031M | -9.831M | -17.55% |
| Q2 2019 Q2Q % growth | 39.1M | 43.619M | -4.519M | -10.36% |
| Q1 2019 Q2Q % growth | 56.9M | 69.159M | -12.259M | -17.73% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -5.03% | -11.22% | -2.97% | 1.34% |
| Revenue | -1.37% | -11.01% | 0.17% | 2.89% |